These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 27552275)
1. Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial. Pasick RJ; Joseph G; Stewart S; Kaplan C; Lee R; Luce J; Davis S; Marquez T; Nguyen T; Guerra C Am J Public Health; 2016 Oct; 106(10):1842-8. PubMed ID: 27552275 [TBL] [Abstract][Full Text] [Related]
2. Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach. Joseph G; Kaplan C; Luce J; Lee R; Stewart S; Guerra C; Pasick R Public Health Genomics; 2012; 15(3-4):172-80. PubMed ID: 22488460 [TBL] [Abstract][Full Text] [Related]
3. Impact of Implementing B-RST Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475 [TBL] [Abstract][Full Text] [Related]
4. Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer. Sutton AL; Hurtado-de-Mendoza A; Quillin J; Rubinsak L; Temkin SM; Gal T; Sheppard VB J Womens Health (Larchmt); 2020 Aug; 29(8):1131-1135. PubMed ID: 31794334 [No Abstract] [Full Text] [Related]
5. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter. Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805 [TBL] [Abstract][Full Text] [Related]
6. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling? Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368 [TBL] [Abstract][Full Text] [Related]
7. Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing. Sheppard VB; Mays D; LaVeist T; Tercyak KP J Natl Med Assoc; 2013; 105(1):17-22. PubMed ID: 23862292 [TBL] [Abstract][Full Text] [Related]
8. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients. Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778 [TBL] [Abstract][Full Text] [Related]
9. Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center. Chapman-Davis E; Zhou ZN; Fields JC; Frey MK; Jordan B; Sapra KJ; Chatterjee-Paer S; Carlson AD; Holcomb KM J Gen Intern Med; 2021 Jan; 36(1):35-42. PubMed ID: 32720237 [TBL] [Abstract][Full Text] [Related]
10. Disparities in genetics assessment for women with ovarian cancer: Can we do better? Manrriquez E; Chapman JS; Mak J; Blanco AM; Chen LM Gynecol Oncol; 2018 Apr; 149(1):84-88. PubMed ID: 29605055 [TBL] [Abstract][Full Text] [Related]
11. [Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers]. Bürki N Ther Umsch; 2010 Jul; 67(7):359-66. PubMed ID: 20577964 [TBL] [Abstract][Full Text] [Related]
12. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals. Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682 [TBL] [Abstract][Full Text] [Related]
13. Germline BRCA Mutation Rates in Latina Women Presenting for Gynecologic Oncology Care. Hong L; Gonzalez R; Unternaehrer J; Ioffe Y Gynecol Obstet Invest; 2020; 85(3):214-221. PubMed ID: 32203957 [TBL] [Abstract][Full Text] [Related]
14. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian. Hessock M; Brewer T; Hutson S; Anderson J Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system. Powell CB; Laurent C; Garcia C; Hoodfar E; Karlea A; Kobelka C; Lee J; Roh J; Kushi LH Clin Genet; 2022 Mar; 101(3):324-334. PubMed ID: 34927729 [TBL] [Abstract][Full Text] [Related]
16. Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer. Gammon AD; Rothwell E; Simmons R; Lowery JT; Ballinger L; Hill DA; Boucher KM; Kinney AY J Genet Couns; 2011 Dec; 20(6):625-38. PubMed ID: 21691939 [TBL] [Abstract][Full Text] [Related]
17. Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations. Thompson HS; Sussner K; Schwartz MD; Edwards T; Forman A; Jandorf L; Brown K; Bovbjerg DH; Valdimarsdottir HB Genet Test Mol Biomarkers; 2012 Nov; 16(11):1257-62. PubMed ID: 23057569 [TBL] [Abstract][Full Text] [Related]
18. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Durfy SJ; Bowen DJ; McTiernan A; Sporleder J; Burke W Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):369-75. PubMed ID: 10207642 [TBL] [Abstract][Full Text] [Related]
19. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial. Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397 [TBL] [Abstract][Full Text] [Related]
20. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations. Khabele D; Runowicz CD Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]